Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Endoscopy × Gastrointestinal × Clear all

Phase

Status

Completed 17 Recruiting 10 Unknown 7 Not yet recruiting 5 Active not recruiting 4 Terminated 2 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Gastrointestinal 1

Conditions

Barrett Esophagus 1

Interventions

Fluorouracil 45 Oxaliplatin 43 Leucovorin 36 Gemcitabine 35 Capecitabine 30 Bevacizumab 24 Irinotecan 22 Radiotherapy 17 Cisplatin 17 pembrolizumab 16 Radiosurgery 15 Nivolumab 14 Cetuximab 14 Taxes 12 Sorafenib 12 Biopsy 12 Surgical Procedures, Operative 11 Paclitaxel 11 lenvatinib 9 Radiation 9 Cyclophosphamide 8 spartalizumab 7 fludarabine 7 durvalumab 7 atezolizumab 7 aflibercept 7 S 1 (combination) 7 Magnetic Resonance Spectroscopy 7 Folfox protocol 7 Drug Therapy 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01209013 2012-05-08

Oedisse

Pinnacle Biologics Inc.

Phase 3 Withdrawn

Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡